127 related articles for article (PubMed ID: 38523384)
1. Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center.
Jang JY; Park JH; Kim YJ; Im HJ; Koh KN; Kim H; Kang SH; Kim HU; Ahn SD
Turk J Pediatr; 2024; 66(1):99-109. PubMed ID: 38523384
[TBL] [Abstract][Full Text] [Related]
2. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.
Ferris MJ; Danish H; Switchenko JM; Deng C; George BA; Goldsmith KC; Wasilewski KJ; Cash WT; Khan MK; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):806-812. PubMed ID: 28244417
[TBL] [Abstract][Full Text] [Related]
3. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
4. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
5. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
7. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Casey DL; Pitter KL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1204-1209. PubMed ID: 29439882
[TBL] [Abstract][Full Text] [Related]
8. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Kushner BH; Wolden S; LaQuaglia MP; Kramer K; Verbel D; Heller G; Cheung NK
J Clin Oncol; 2001 Jun; 19(11):2821-8. PubMed ID: 11387353
[TBL] [Abstract][Full Text] [Related]
10. Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?
Lucas JT; McCarville MB; Cooper DA; Doubrovin M; Wakefield D; Santiago T; Li Y; Li X; Krasin M; Santana V; Furman W; Davidoff AM
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):869-877. PubMed ID: 30496881
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
[TBL] [Abstract][Full Text] [Related]
12. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single-institution experience and review of the literature.
Lee AC; Chui CH; Kwok R; Lee KS; Fong CM; Wong WH
Singapore Med J; 2023 May; 64(5):319-325. PubMed ID: 34688228
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
[TBL] [Abstract][Full Text] [Related]
15. Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.
Hill-Kayser CE; Tochner Z; Li Y; Kurtz G; Lustig RA; James P; Balamuth N; Womer R; Mattei P; Grupp S; Mosse YP; Maris JM; Bagatell R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):401-408. PubMed ID: 30738983
[TBL] [Abstract][Full Text] [Related]
16. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
Haas-Kogan DA; Swift PS; Selch M; Haase GM; Seeger RC; Gerbing RB; Stram DO; Matthay KK
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):28-39. PubMed ID: 12694821
[TBL] [Abstract][Full Text] [Related]
17. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Mazloom A; Louis CU; Nuchtern J; Kim E; Russell H; Allen-Rhoades W; Krance R; Paulino AC
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):858-62. PubMed ID: 25245583
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
Sibley GS; Mundt AJ; Goldman S; Nachman J; Reft C; Weichselbaum RR; Hallahan DE; Johnson L
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1127-35. PubMed ID: 7607934
[TBL] [Abstract][Full Text] [Related]
20. Consolidative high-dose thoracic radiotherapy for limited metastatic nonsmall cell lung cancer: Focusing on oligo-progressive disease.
Kim H; Yang DS; Kim SM
Asia Pac J Clin Oncol; 2023 Jun; 19(3):385-391. PubMed ID: 36464919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
